Total Payments
$3,052
2024 Payments
$1,376
Companies
19
Transactions
33
Medicare Patients
1,393
Medicare Billing
$85,597
Payment Breakdown by Category
Food & Beverage$3,052 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,052 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $440.12 | 4 | $0 (2024) |
| Novo Nordisk Inc | $354.30 | 6 | $0 (2024) |
| Abbott Laboratories | $315.71 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $224.39 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $207.27 | 2 | $0 (2022) |
| Edwards Lifesciences Corporation | $179.18 | 2 | $0 (2024) |
| Lilly USA, LLC | $135.06 | 2 | $0 (2024) |
| Medtronic, Inc. | $133.20 | 1 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $127.41 | 1 | $0 (2023) |
| Tempus AI, Inc | $124.37 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,376 | 15 | Teva Pharmaceuticals USA, Inc. ($224.39) |
| 2023 | $652.01 | 6 | Abbott Laboratories ($171.07) |
| 2022 | $862.46 | 9 | Novo Nordisk Inc ($229.08) |
| 2021 | $161.27 | 3 | Janssen Pharmaceuticals, Inc ($119.43) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $152.58 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $144.64 | General |
| Category: Diabetes Care | ||||||
| 11/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $119.84 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $124.37 | General |
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Central Nervous System | ||||||
| 06/05/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $122.12 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/04/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $119.82 | General |
| Category: Obesity | ||||||
| 04/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $96.66 | General |
| Category: Respiratory | ||||||
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $95.18 | General |
| Category: Neurology | ||||||
| 03/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $97.53 | General |
| Category: Obesity | ||||||
| 02/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $116.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Neurology | ||||||
| 01/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $122.49 | General |
| Category: Central Nervous System | ||||||
| 12/26/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $171.07 | General |
| Category: Diabetes Care | ||||||
| 09/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 08/04/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $119.68 | General |
| Category: Cardiology | ||||||
| 05/16/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $121.04 | General |
| Category: VIROLOGY | ||||||
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $98.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $127.41 | General |
| Category: Neuropsychiatry | ||||||
| 12/08/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $125.20 | General |
| Category: Respiratory | ||||||
| 11/09/2022 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $117.75 | General |
| Category: Obesity | ||||||
| 11/09/2022 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Obesity | ||||||
| 11/05/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $96.66 | General |
| Category: INSOMNIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 230 | 361 | $53,393 | $19,897 |
| 2022 | 9 | 359 | 486 | $61,405 | $23,303 |
| 2021 | 10 | 432 | 521 | $53,784 | $24,117 |
| 2020 | 10 | 372 | 493 | $54,004 | $18,280 |
Total Patients
1,393
Total Services
1,861
Medicare Billing
$85,597
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 127 | $27,990 | $8,713 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 38 | 38 | $8,550 | $4,019 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 65 | $10,384 | $3,687 | 35.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 22 | 23 | $2,757 | $1,727 | 62.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 23 | $1,491 | $684.25 | 45.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 46 | $931.00 | $437.92 | 47.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $710.00 | $327.25 | 46.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $345.00 | $165.22 | 47.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 17 | $235.00 | $135.80 | 57.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 123 | $27,113 | $8,878 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $11,475 | $5,540 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 91 | $14,346 | $4,651 | 32.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 15 | 15 | $1,766 | $1,050 | 59.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 57 | 57 | $1,767 | $880.74 | 49.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 54 | 54 | $1,674 | $819.97 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 31 | 65 | $1,365 | $623.18 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $1,067 | $486.61 | 45.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $832.00 | $373.41 | 44.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 113 | $21,212 | $8,021 | 37.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 102 | $12,951 | $5,458 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $9,520 | $5,247 | 55.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 35 | 35 | $3,500 | $2,325 | 66.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 56 | 56 | $1,736 | $875.28 | 50.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 41 | 41 | $1,290 | $640.83 | 49.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 37 | 37 | $1,591 | $613.09 | 38.5% |
About Carol Harrington, ARNP
Carol Harrington, ARNP is a Primary Care healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124018437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carol Harrington, ARNP has received a total of $3,052 in payments from pharmaceutical and medical device companies, with $1,376 received in 2024. These payments were reported across 33 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,052).
As a Medicare-enrolled provider, Harrington has provided services to 1,393 Medicare beneficiaries, totaling 1,861 services with total Medicare billing of $85,597. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Primary Care, Primary Care
- Location Independence, MO
- Active Since 10/27/2005
- Last Updated 11/29/2021
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1124018437
Products in Payments
- FREESTYLE LIBRE 3 (Device) $315.71
- Wegovy (Drug) $230.93
- AIRSUPRA (Drug) $216.50
- XARELTO (Drug) $207.27
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $152.58
- NA (Device) $133.20
- Austedo XR (Drug) $129.21
- INGREZZA (Drug) $127.41
- FASENRA (Biological) $125.20
- NURTEC ODT (Drug) $124.07
- QUTENZA (Drug) $122.12
- MAVYRET (Drug) $121.04
- ZEPBOUND (Drug) $119.82
- FUROSCIX (Drug) $119.68
- LEQVIO (Drug) $116.97
- FARXIGA (Drug) $98.42
- QUVIVIQ (Drug) $96.66
- Rybelsus (Drug) $95.68
- UZEDY (Drug) $95.18
- Embozene (Device) $66.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Independence
Rosemarie Lazo
Primary Care — Payments: $645.16
Primary Care $645.16
Stephanie Salter, Aprn, Agpcnp, APRN, AGPCNP
Primary Care — Payments: $45.40
Primary Care $45.40
Melanie Tran
Primary Care — Payments: $27.82
Primary Care $27.82
Ms. Doris O'reilly-Dillon, Np-C, NP-C
Primary Care
Primary Care
Allyson Lavinder, Arnp, ARNP
Primary Care
Primary Care
Mrs. Marianna Lanigan, Msn, Aprn, A-Gnp-C, MSN, APRN, A-GNP-C
Primary Care
Primary Care